541539-64-4 Usage
Description
5-Acetamido-2-bromo-1,3-difluorobenzene is a chemical compound characterized by its molecular formula C8H6BrF2NO. It is a white solid with a molecular weight of 237.04 g/mol. 5-Acetamido-2-bromo-1,3-difluorobenzene is recognized for its unique structure and properties, making it a valuable building block in organic synthesis across various industries.
Uses
Used in Pharmaceutical Industry:
5-Acetamido-2-bromo-1,3-difluorobenzene is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its unique structure allows it to be a key component in creating molecules with specific therapeutic properties.
Used in Organic Compounds Synthesis:
In the field of organic chemistry, 5-Acetamido-2-bromo-1,3-difluorobenzene is utilized as a versatile intermediate, facilitating the creation of a wide range of organic compounds for various applications.
Used in Agrochemical Production:
5-Acetamido-2-bromo-1,3-difluorobenzene is employed in the production of agrochemicals, where it serves as a crucial intermediate for developing compounds that can enhance crop protection and yield.
Used in Specialty Chemicals Industry:
5-Acetamido-2-bromo-1,3-difluorobenzene is also used in the manufacture of specialty chemicals, where its distinctive properties are leveraged to produce high-value products for niche applications.
Check Digit Verification of cas no
The CAS Registry Mumber 541539-64-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,4,1,5,3 and 9 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 541539-64:
(8*5)+(7*4)+(6*1)+(5*5)+(4*3)+(3*9)+(2*6)+(1*4)=154
154 % 10 = 4
So 541539-64-4 is a valid CAS Registry Number.
541539-64-4Relevant articles and documents
QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR
-
Page/Page column 30, (2021/07/24)
The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.